Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of HMS5552 in patients with Type 2 diabetes mellitus. The trial is sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HMS5552

Snippet

Sponsor: Hua Medicine Limited | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED